BPTH
Bio-Path Holdings Inc

17,972
Mkt Cap
$589,860.00
Volume
36,189.00
52W High
$0.2316
52W Low
$0.0549
PE Ratio
-0.04
BPTH Fundamentals
Price
$0.08
Prev Close
$0.071
Open
$0.07
50D MA
$0.0797
Beta
0.93
Avg. Volume
24,235.05
EPS (Annual)
-$4.12
P/B
-0.09
Rev/Employee
$0.00
Loading...
Loading...
Bio-Path Holdings, Inc. is a biotechnology company, which engages in the development of therapies for acute myeloid leukemia (AML) and chronic myeloid leukemia (CML). Its product pipeline includes Prexigebersen, BP1001-A, BP1002, and BP1003. The company was founded by Peter H. Nielsen, Douglas P. Morris, Gabriel Lopez-Berestein and Ana Tari Ashizawa on May 10, 2007 and is headquartered in Bellaire, TX.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
10

Frequently Asked Questions

What is Market Cap of Bio-Path Holdings Inc?
What is the 52-week high for Bio-Path Holdings Inc?
What is the 52-week low for Bio-Path Holdings Inc?
What is Bio-Path Holdings Inc stock price today?
What was Bio-Path Holdings Inc stock price yesterday?
What is the PE ratio of Bio-Path Holdings Inc?
What is the Price-to-Book ratio of Bio-Path Holdings Inc?
What is the 50-day moving average of Bio-Path Holdings Inc?
How many employess does Bio-Path Holdings Inc has?

Latest BPTH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.